ANAPTYSBIO INC's ticker is ANAB and the CUSIP is 032724106. A total of 124 filers reported holding ANAPTYSBIO INC in Q1 2021. The put-call ratio across all filers is 1.06 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,335,000 | -29.8% | 53,963 | -1.5% | 0.00% | 0.0% |
| Q4 2021 | $1,903,000 | +22.5% | 54,757 | -4.4% | 0.00% | 0.0% |
| Q3 2021 | $1,553,000 | +18.0% | 57,279 | +12.9% | 0.00% | 0.0% |
| Q2 2021 | $1,316,000 | +13.3% | 50,735 | -5.9% | 0.00% | 0.0% |
| Q1 2021 | $1,162,000 | +15.2% | 53,938 | +14.9% | 0.00% | 0.0% |
| Q4 2020 | $1,009,000 | +83.5% | 46,935 | +25.9% | 0.00% | – |
| Q3 2020 | $550,000 | -26.5% | 37,288 | +11.4% | 0.00% | -100.0% |
| Q2 2020 | $748,000 | +10.5% | 33,461 | -30.1% | 0.00% | 0.0% |
| Q1 2020 | $677,000 | +13.0% | 47,877 | +29.8% | 0.00% | – |
| Q4 2019 | $599,000 | +93.9% | 36,889 | +318.0% | 0.00% | – |
| Q3 2019 | $309,000 | -4.0% | 8,826 | +54.5% | 0.00% | – |
| Q2 2019 | $322,000 | +58.6% | 5,714 | +181.2% | 0.00% | – |
| Q3 2018 | $203,000 | – | 2,032 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 3,688,448 | $102,354,000 | 54.68% |
| Novo Holdings A/S | 3,033,504 | $84,180,000 | 8.96% |
| BVF INC/IL | 1,738,600 | $48,246,000 | 8.21% |
| Cormorant Asset Management, LP | 895,626 | $24,854,000 | 3.61% |
| Perceptive Advisors | 881,957 | $24,474,000 | 1.39% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 100,500 | $2,789,000 | 1.07% |
| ACUTA CAPITAL PARTNERS, LLC | 165,690 | $4,138,000 | 0.98% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 845,746 | $23,469,000 | 0.90% |
| Iguana Healthcare Management, LLC | 50,000 | $1,388,000 | 0.69% |
| Boxer Capital, LLC | 50,000 | $1,388,000 | 0.30% |